JP2013544893A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013544893A5 JP2013544893A5 JP2013543335A JP2013543335A JP2013544893A5 JP 2013544893 A5 JP2013544893 A5 JP 2013544893A5 JP 2013543335 A JP2013543335 A JP 2013543335A JP 2013543335 A JP2013543335 A JP 2013543335A JP 2013544893 A5 JP2013544893 A5 JP 2013544893A5
- Authority
- JP
- Japan
- Prior art keywords
- carboxamide
- pyrimidine
- difluoromethyl
- alkyl
- dihydropyrazolo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 cyano, nitro, amino Chemical group 0.000 claims 47
- 125000000217 alkyl group Chemical group 0.000 claims 39
- 125000001424 substituent group Chemical group 0.000 claims 29
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 28
- 229910052736 halogen Inorganic materials 0.000 claims 27
- 150000002367 halogens Chemical class 0.000 claims 27
- 150000001875 compounds Chemical class 0.000 claims 26
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 26
- 229910052739 hydrogen Inorganic materials 0.000 claims 22
- 239000001257 hydrogen Substances 0.000 claims 22
- 125000003545 alkoxy group Chemical group 0.000 claims 20
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims 20
- 239000008194 pharmaceutical composition Substances 0.000 claims 14
- 150000003839 salts Chemical class 0.000 claims 14
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 13
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 10
- 125000003282 alkyl amino group Chemical group 0.000 claims 9
- 125000004438 haloalkoxy group Chemical group 0.000 claims 9
- 125000001188 haloalkyl group Chemical group 0.000 claims 9
- 150000002431 hydrogen Chemical class 0.000 claims 9
- 125000004076 pyridyl group Chemical group 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 7
- 125000005842 heteroatom Chemical group 0.000 claims 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 6
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- 125000003342 alkenyl group Chemical group 0.000 claims 5
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 5
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 claims 4
- 125000000304 alkynyl group Chemical group 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 4
- 125000001070 dihydroindolyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 claims 4
- 125000002950 monocyclic group Chemical group 0.000 claims 4
- 125000001624 naphthyl group Chemical group 0.000 claims 4
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims 4
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 4
- 125000001054 5 membered carbocyclic group Chemical group 0.000 claims 3
- 125000004008 6 membered carbocyclic group Chemical group 0.000 claims 3
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 3
- 125000001118 alkylidene group Chemical group 0.000 claims 3
- 125000004122 cyclic group Chemical group 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 3
- LPCQBTAOTIZGAE-UHFFFAOYSA-N 2h-pyrimidine-1-carboxamide Chemical compound NC(=O)N1CN=CC=C1 LPCQBTAOTIZGAE-UHFFFAOYSA-N 0.000 claims 2
- SNXQLBHDNMAMCD-UHFFFAOYSA-N 7-(3,5-dimethylmorpholin-4-yl)-n-(4-ethylphenyl)-5-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=CC(CC)=CC=C1NC(=O)C1=C2N=C(C)C=C(N3C(COCC3C)C)N2N=C1 SNXQLBHDNMAMCD-UHFFFAOYSA-N 0.000 claims 2
- OESWFRMZSUAEDJ-UHFFFAOYSA-N 7-(3,5-dimethylpiperazin-1-yl)-n-(4-ethylphenyl)-5-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=CC(CC)=CC=C1NC(=O)C1=C2N=C(C)C=C(N3CC(C)NC(C)C3)N2N=C1 OESWFRMZSUAEDJ-UHFFFAOYSA-N 0.000 claims 2
- YFKXHYCAXKALMF-UHFFFAOYSA-N 7-[4-[2-(dimethylamino)ethyl]piperazin-1-yl]-n-(4-ethylphenyl)-5-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=CC(CC)=CC=C1NC(=O)C1=C2N=C(C)C=C(N3CCN(CCN(C)C)CC3)N2N=C1 YFKXHYCAXKALMF-UHFFFAOYSA-N 0.000 claims 2
- 241000282376 Panthera tigris Species 0.000 claims 2
- 125000005431 alkyl carboxamide group Chemical group 0.000 claims 2
- 125000005907 alkyl ester group Chemical group 0.000 claims 2
- 125000004414 alkyl thio group Chemical group 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 125000002619 bicyclic group Chemical group 0.000 claims 2
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 2
- 125000001589 carboacyl group Chemical group 0.000 claims 2
- NBVXSTLIUNQXBT-UHFFFAOYSA-N chembl3185251 Chemical compound CCOC1=CC=CC=C1NC(=O)C1=C(NC(=C)C=C2C(F)F)N2N=C1 NBVXSTLIUNQXBT-UHFFFAOYSA-N 0.000 claims 2
- 125000004639 dihydroindenyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- YHCDLYUQTOQNLN-UHFFFAOYSA-N n-(4-ethylphenyl)-5-methyl-7-(4-methylpiperazin-1-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=CC(CC)=CC=C1NC(=O)C1=C2N=C(C)C=C(N3CCN(C)CC3)N2N=C1 YHCDLYUQTOQNLN-UHFFFAOYSA-N 0.000 claims 2
- CHFXTFMIFBNPSJ-UHFFFAOYSA-N n-(4-ethylphenyl)-5-methyl-7-[4-(2-methylpropyl)piperazin-1-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=CC(CC)=CC=C1NC(=O)C1=C2N=C(C)C=C(N3CCN(CC(C)C)CC3)N2N=C1 CHFXTFMIFBNPSJ-UHFFFAOYSA-N 0.000 claims 2
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims 2
- KLFXDMIVOKQLJQ-UHFFFAOYSA-N (5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)-[4-(4-nitrophenyl)piperazin-1-yl]methanone Chemical compound C=12N=C(C)C=C(C)N2N=CC=1C(=O)N(CC1)CCN1C1=CC=C([N+]([O-])=O)C=C1 KLFXDMIVOKQLJQ-UHFFFAOYSA-N 0.000 claims 1
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 1
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims 1
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 1
- 125000006582 (C5-C6) heterocycloalkyl group Chemical group 0.000 claims 1
- 125000004484 1-methylpiperidin-4-yl group Chemical group CN1CCC(CC1)* 0.000 claims 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims 1
- ONGSAYSLHZBWEP-UHFFFAOYSA-N 5,7-dimethyl-n-[3-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C=12N=C(C)C=C(C)N2N=CC=1C(=O)NC1=CC=CC(C(F)(F)F)=C1 ONGSAYSLHZBWEP-UHFFFAOYSA-N 0.000 claims 1
- YBKYTNNBXFZNFF-UHFFFAOYSA-N 5,7-dimethyl-n-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C=12N=C(C)C=C(C)N2N=CC=1C(=O)NC1=CC=C(C(F)(F)F)C=C1 YBKYTNNBXFZNFF-UHFFFAOYSA-N 0.000 claims 1
- CYEFRDZGYTWHFV-UHFFFAOYSA-N 5-cyclopropylidene-7-(difluoromethyl)-N-(3,4-difluorophenyl)-4H-pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1=CC=C(F)C(F)=C1 CYEFRDZGYTWHFV-UHFFFAOYSA-N 0.000 claims 1
- AWDMEPYOBMQXRW-UHFFFAOYSA-N 5-cyclopropylidene-7-(difluoromethyl)-N-(4-sulfamoylphenyl)-4H-pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=CC(S(=O)(=O)N)=CC=C1NC(=O)C1=C(NC(C=C2C(F)F)=C3CC3)N2N=C1 AWDMEPYOBMQXRW-UHFFFAOYSA-N 0.000 claims 1
- GTZRFXVCWJKLEH-UHFFFAOYSA-N 5-cyclopropylidene-7-(difluoromethyl)-N-(6-methylpyridin-2-yl)-4H-pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound CC1=CC=CC(NC(=O)C2=C3N(C(=CC(N3)=C3CC3)C(F)F)N=C2)=N1 GTZRFXVCWJKLEH-UHFFFAOYSA-N 0.000 claims 1
- PFBZJDASYDABLN-UHFFFAOYSA-N 5-cyclopropylidene-N-(3,5-dichlorophenyl)-7-(difluoromethyl)-4H-pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1=CC(Cl)=CC(Cl)=C1 PFBZJDASYDABLN-UHFFFAOYSA-N 0.000 claims 1
- VCRFPNNYMJNLSQ-UHFFFAOYSA-N 7-(difluoromethyl)-5-methyl-n-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C=12N=C(C)C=C(C(F)F)N2N=CC=1C(=O)NC1=CC=C(C(F)(F)F)C=C1 VCRFPNNYMJNLSQ-UHFFFAOYSA-N 0.000 claims 1
- WICPNVMYTPNMIV-UHFFFAOYSA-N 7-(difluoromethyl)-n-(4-ethynylphenyl)-5-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C=12N=C(C)C=C(C(F)F)N2N=CC=1C(=O)NC1=CC=C(C#C)C=C1 WICPNVMYTPNMIV-UHFFFAOYSA-N 0.000 claims 1
- PMWQSQNHUBGLLI-UHFFFAOYSA-N 7-methyl-N-[4-(trifluoromethyl)phenyl]-1,8,12-triazatricyclo[7.3.0.02,6]dodeca-2(6),7,9,11-tetraene-10-carboxamide Chemical compound C1=NN2C=3CCCC=3C(C)=NC2=C1C(=O)NC1=CC=C(C(F)(F)F)C=C1 PMWQSQNHUBGLLI-UHFFFAOYSA-N 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 101150028412 GBA gene Proteins 0.000 claims 1
- 208000015872 Gaucher disease Diseases 0.000 claims 1
- 206010064571 Gene mutation Diseases 0.000 claims 1
- 108010017544 Glucosylceramidase Proteins 0.000 claims 1
- 102100033342 Lysosomal acid glucosylceramidase Human genes 0.000 claims 1
- IJHKKHPENYDANX-UHFFFAOYSA-N N-(2,3-dihydro-1H-inden-5-yl)-5,7-dimethyl-3-pyrazolo[1,5-a]pyrimidinecarboxamide Chemical compound C1=C2CCCC2=CC(NC(=O)C=2C=NN3C(C)=CC(=NC3=2)C)=C1 IJHKKHPENYDANX-UHFFFAOYSA-N 0.000 claims 1
- XUPMMFBGZQUWOI-UHFFFAOYSA-N N-(3,4-dichlorophenyl)-7-methyl-1,8,12-triazatricyclo[7.3.0.02,6]dodeca-2(6),7,9,11-tetraene-10-carboxamide Chemical compound C1=NN2C=3CCCC=3C(C)=NC2=C1C(=O)NC1=CC=C(Cl)C(Cl)=C1 XUPMMFBGZQUWOI-UHFFFAOYSA-N 0.000 claims 1
- OEPHUHZIEWQNMV-UHFFFAOYSA-N N-(4-bromo-2-chlorophenyl)-5-cyclopropylidene-7-(difluoromethyl)-4H-pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1=CC=C(Br)C=C1Cl OEPHUHZIEWQNMV-UHFFFAOYSA-N 0.000 claims 1
- YLOVOAWHCHJWRE-UHFFFAOYSA-N N-(4-bromophenyl)-5-cyclopropylidene-7-(difluoromethyl)-4H-pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1=CC=C(Br)C=C1 YLOVOAWHCHJWRE-UHFFFAOYSA-N 0.000 claims 1
- ZVARWXBKZUMXPQ-UHFFFAOYSA-N N-(4-ethylphenyl)-7-methyl-1,8,12-triazatricyclo[7.3.0.02,6]dodeca-2(6),7,9,11-tetraene-10-carboxamide Chemical compound C1=CC(CC)=CC=C1NC(=O)C1=C2N=C(C)C(CCC3)=C3N2N=C1 ZVARWXBKZUMXPQ-UHFFFAOYSA-N 0.000 claims 1
- OHQBGXMWKGOOAQ-UHFFFAOYSA-N N-(4-ethynylphenyl)-7-methyl-1,8,12-triazatricyclo[7.3.0.02,6]dodeca-2(6),7,9,11-tetraene-10-carboxamide Chemical compound C1=NN2C=3CCCC=3C(C)=NC2=C1C(=O)NC1=CC=C(C#C)C=C1 OHQBGXMWKGOOAQ-UHFFFAOYSA-N 0.000 claims 1
- LSYHYTOVOAOWMT-UHFFFAOYSA-N N-(4-tert-butylcyclohexyl)-7-methyl-1,8,12-triazatricyclo[7.3.0.02,6]dodeca-2(6),7,9,11-tetraene-10-carboxamide Chemical compound C1=NN2C=3CCCC=3C(C)=NC2=C1C(=O)NC1CCC(C(C)(C)C)CC1 LSYHYTOVOAOWMT-UHFFFAOYSA-N 0.000 claims 1
- GGBNAHMOTCFJHS-UHFFFAOYSA-N N-(5-bromopyridin-2-yl)-5-cyclopropylidene-7-(difluoromethyl)-4H-pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1=CC=C(Br)C=N1 GGBNAHMOTCFJHS-UHFFFAOYSA-N 0.000 claims 1
- XLUAAOIBRIUDQP-UHFFFAOYSA-N N-[(2-chlorophenyl)methyl]-7-(difluoromethyl)-5-methylidene-4H-pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=NN2C(C(F)F)=CC(=C)NC2=C1C(=O)NCC1=CC=CC=C1Cl XLUAAOIBRIUDQP-UHFFFAOYSA-N 0.000 claims 1
- QGCNZLGLSRHLQF-LUIVOBPISA-N N-[(2E,4E)-hexa-2,4-dien-2-yl]-7-methyl-1,8,12-triazatricyclo[7.3.0.02,6]dodeca-2(6),7,9,11-tetraene-10-carboxamide Chemical compound CC1=NC2=C(C(=O)NC(/C)=C/C=C/C)C=NN2C2=C1CCC2 QGCNZLGLSRHLQF-LUIVOBPISA-N 0.000 claims 1
- ZFIIFXLGSQPYGE-UHFFFAOYSA-N N-[(4-chlorophenyl)methyl]-7-(difluoromethyl)-5-methylidene-4H-pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=NN2C(C(F)F)=CC(=C)NC2=C1C(=O)NCC1=CC=C(Cl)C=C1 ZFIIFXLGSQPYGE-UHFFFAOYSA-N 0.000 claims 1
- UGTVODMYDKHASE-UHFFFAOYSA-N N-butan-2-yl-7-(difluoromethyl)-5-methylidene-4H-pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound N1C(=C)C=C(C(F)F)N2C1=C(C(=O)NC(C)CC)C=N2 UGTVODMYDKHASE-UHFFFAOYSA-N 0.000 claims 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims 1
- PWYSFEDEWYZHQH-UHFFFAOYSA-N [7-(difluoromethyl)-5-methylidene-4H-pyrazolo[1,5-a]pyrimidin-3-yl]-(4-pyridin-2-ylpiperazin-1-yl)methanone Chemical compound C1=NN2C(C(F)F)=CC(=C)NC2=C1C(=O)N(CC1)CCN1C1=CC=CC=N1 PWYSFEDEWYZHQH-UHFFFAOYSA-N 0.000 claims 1
- XMBVLXDWUPESNP-UHFFFAOYSA-N [7-(difluoromethyl)-5-methylidene-4H-pyrazolo[1,5-a]pyrimidin-3-yl]-piperidin-1-ylmethanone Chemical compound C1=NN2C(C(F)F)=CC(=C)NC2=C1C(=O)N1CCCCC1 XMBVLXDWUPESNP-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 150000003857 carboxamides Chemical class 0.000 claims 1
- BLWPNCPHSRWMOK-UHFFFAOYSA-N chembl1714232 Chemical compound N1C2=C(C(=O)NC=3C=C4CCCC4=CC=3)C=NN2C(C(F)F)=CC1=C1CC1 BLWPNCPHSRWMOK-UHFFFAOYSA-N 0.000 claims 1
- XPZTZQKJXDOKPR-UHFFFAOYSA-N chembl1716885 Chemical compound C1=NN2C(C(F)(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1=CC=CC=C1SC1=CC=CC=C1 XPZTZQKJXDOKPR-UHFFFAOYSA-N 0.000 claims 1
- IUJQOWDONOIJRD-UHFFFAOYSA-N chembl1723999 Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1CCCCC1 IUJQOWDONOIJRD-UHFFFAOYSA-N 0.000 claims 1
- YHAVWNXZFBVYOJ-UHFFFAOYSA-N chembl1725455 Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1=CC=CC=C1SC1=CC=CC=C1 YHAVWNXZFBVYOJ-UHFFFAOYSA-N 0.000 claims 1
- ZJTWTDPHRBJXQN-UHFFFAOYSA-N chembl1867541 Chemical compound C1=C(OC)C(OC)=CC=C1CCNC(=O)C1=C(NC(C=C2C(F)F)=C3CC3)N2N=C1 ZJTWTDPHRBJXQN-UHFFFAOYSA-N 0.000 claims 1
- AAWGXKDFFFEINN-UHFFFAOYSA-N chembl1870221 Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1=CC=CN=C1Cl AAWGXKDFFFEINN-UHFFFAOYSA-N 0.000 claims 1
- FZGYHQIVTONTQY-UHFFFAOYSA-N chembl1873702 Chemical compound C1=NN2C(C(F)F)=CC(=C)NC2=C1C(=O)NC1=CC=C(Br)C=C1C(F)(F)F FZGYHQIVTONTQY-UHFFFAOYSA-N 0.000 claims 1
- WFCTUWCTLULDLZ-UHFFFAOYSA-N chembl1874145 Chemical compound C1=CC([N+](=O)[O-])=CC=C1NC(=O)C1=C(NC(C=C2C(F)F)=C3CC3)N2N=C1 WFCTUWCTLULDLZ-UHFFFAOYSA-N 0.000 claims 1
- MUEZEYDZQXQLNT-UHFFFAOYSA-N chembl1876337 Chemical compound N1=CC=C2C(NC(=O)C3=C4NC(=C)C=C(N4N=C3)C)=CC=CC2=C1 MUEZEYDZQXQLNT-UHFFFAOYSA-N 0.000 claims 1
- YRUSMPLCKKPXOR-UHFFFAOYSA-N chembl1878874 Chemical compound C1=CC(N(CC)CC)=CC=C1NC(=O)C1=C(NC(=C)C=C2C(F)F)N2N=C1 YRUSMPLCKKPXOR-UHFFFAOYSA-N 0.000 claims 1
- BFGMJVMDZAXEHA-UHFFFAOYSA-N chembl1881090 Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1=CC=CC=C1Br BFGMJVMDZAXEHA-UHFFFAOYSA-N 0.000 claims 1
- OHSZLQMKXVFEFE-UHFFFAOYSA-N chembl1881290 Chemical compound C1=NN2C(C(F)F)=CC(=C)NC2=C1C(=O)NCC1=CC=C(Cl)C=C1Cl OHSZLQMKXVFEFE-UHFFFAOYSA-N 0.000 claims 1
- RLJJHFBZZBETKS-UHFFFAOYSA-N chembl1885887 Chemical compound C1=NN2C(C)=CC(=C)NC2=C1C(=O)NC1=CC=CC=C1O RLJJHFBZZBETKS-UHFFFAOYSA-N 0.000 claims 1
- LGECWDNOBJRGIQ-UHFFFAOYSA-N chembl1886380 Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1=CC=C(Br)C=C1F LGECWDNOBJRGIQ-UHFFFAOYSA-N 0.000 claims 1
- OJSDGCOLPKPYAZ-UHFFFAOYSA-N chembl1887267 Chemical compound C1CC(C(C)(C)C)CCC1NC(=O)C1=C(NC(C=C2C(F)F)=C3CC3)N2N=C1 OJSDGCOLPKPYAZ-UHFFFAOYSA-N 0.000 claims 1
- IOKDCCFJHGEPMK-UHFFFAOYSA-N chembl1887655 Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1=CC=CC=C1F IOKDCCFJHGEPMK-UHFFFAOYSA-N 0.000 claims 1
- GJUOWWGQGDXQBK-UHFFFAOYSA-N chembl1890316 Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1=CC=C(Cl)C=C1Cl GJUOWWGQGDXQBK-UHFFFAOYSA-N 0.000 claims 1
- KFBQUEJISGCYFS-UHFFFAOYSA-N chembl1893463 Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1=CC=C(Cl)C=N1 KFBQUEJISGCYFS-UHFFFAOYSA-N 0.000 claims 1
- ZOPRAITYHAXVHL-UHFFFAOYSA-N chembl1896615 Chemical compound C1=C(F)C(F)=CC=C1NC(=O)C1=C(NC(C=C2C(F)(F)F)=C3CC3)N2N=C1 ZOPRAITYHAXVHL-UHFFFAOYSA-N 0.000 claims 1
- OZPRMVXBPKAGKF-UHFFFAOYSA-N chembl1898529 Chemical compound N1C2=C(C(=O)NC=3C=C4OCCOC4=CC=3)C=NN2C(C(F)F)=CC1=C1CC1 OZPRMVXBPKAGKF-UHFFFAOYSA-N 0.000 claims 1
- MRZWTTHYDRPLGG-UHFFFAOYSA-N chembl1898939 Chemical compound C1=CC(C(=O)C)=CC=C1NC(=O)C1=C(NC(C=C2C(F)F)=C3CC3)N2N=C1 MRZWTTHYDRPLGG-UHFFFAOYSA-N 0.000 claims 1
- GLKUOMQUBDOYPC-UHFFFAOYSA-N chembl1900686 Chemical compound C1=C(C)C(C)=CC=C1NC(=O)C1=C(NC(C=C2C(F)F)=C3CC3)N2N=C1 GLKUOMQUBDOYPC-UHFFFAOYSA-N 0.000 claims 1
- LDRWLVPALRBOFK-UHFFFAOYSA-N chembl1901326 Chemical compound CCC1=CC=CC(NC(=O)C2=C3N(C(=CC(=C)N3)C(F)F)N=C2)=C1 LDRWLVPALRBOFK-UHFFFAOYSA-N 0.000 claims 1
- NYSUCFDGXPZAIB-UHFFFAOYSA-N chembl1901966 Chemical compound C1CC2=CC=CC=C2CN1C(=O)C1=C2NC(=C)C=C(C(F)F)N2N=C1 NYSUCFDGXPZAIB-UHFFFAOYSA-N 0.000 claims 1
- SKRNYDJYGJJKSP-UHFFFAOYSA-N chembl1902051 Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1=CC=C(Cl)C=C1 SKRNYDJYGJJKSP-UHFFFAOYSA-N 0.000 claims 1
- DRYVCCYVIZSNGK-UHFFFAOYSA-N chembl1905484 Chemical compound C1=NN2C(C)=CC(=C)NC2=C1C(=O)N(CC=1C=CC=CC=1)CCC1=CC=CC=C1 DRYVCCYVIZSNGK-UHFFFAOYSA-N 0.000 claims 1
- JOBICGKYHJIXCI-UHFFFAOYSA-N chembl1972759 Chemical compound C1=NN2C(C(F)F)=CC(=C)NC2=C1C(=O)N(CC1)CCN1C1=CC=CC=C1 JOBICGKYHJIXCI-UHFFFAOYSA-N 0.000 claims 1
- CJSKHBXNBHEUJC-UHFFFAOYSA-N chembl2354907 Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1CCCC1 CJSKHBXNBHEUJC-UHFFFAOYSA-N 0.000 claims 1
- BNZGRWSOFVPZMV-UHFFFAOYSA-N chembl2356111 Chemical compound C1=C(Cl)C(NC(=O)C)=CC=C1NC(=O)C1=C(NC(=C)C=C2C)N2N=C1 BNZGRWSOFVPZMV-UHFFFAOYSA-N 0.000 claims 1
- QZTIBCFHYWXKAA-UHFFFAOYSA-N chembl2356724 Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1=CC=NC=C1 QZTIBCFHYWXKAA-UHFFFAOYSA-N 0.000 claims 1
- BAPNOZURPUDGIY-UHFFFAOYSA-N chembl2359282 Chemical compound C1=CC(F)=CC=C1CNC(=O)C1=C(NC(=C)C=C2C(F)(F)F)N2N=C1 BAPNOZURPUDGIY-UHFFFAOYSA-N 0.000 claims 1
- AABGHFWXMGZNOV-UHFFFAOYSA-N chembl2359779 Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC(C=1)=CC=CC=1NC1=CC=CC=C1 AABGHFWXMGZNOV-UHFFFAOYSA-N 0.000 claims 1
- FTLHUAVVOHPWRC-UHFFFAOYSA-N chembl2361241 Chemical compound C1=NN2C(C(F)F)=CC(=C3CC3)NC2=C1C(=O)NC1=CC(F)=CC=C1F FTLHUAVVOHPWRC-UHFFFAOYSA-N 0.000 claims 1
- WJTDUTUTEKJDCL-UHFFFAOYSA-N chembl2361483 Chemical compound N1C2=C(C(=O)NC=3C4=CC=CC=C4C=CC=3)C=NN2C(C(F)F)=CC1=C1CC1 WJTDUTUTEKJDCL-UHFFFAOYSA-N 0.000 claims 1
- JMTYCVAJHIFHHT-UHFFFAOYSA-N chembl2361661 Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=C(NC(=C)C=C2C(F)F)N2N=C1 JMTYCVAJHIFHHT-UHFFFAOYSA-N 0.000 claims 1
- FEHJERVYRFYEKP-UHFFFAOYSA-N chembl2362278 Chemical compound C1=NN2C(C(F)F)=CC(=C)NC2=C1C(=O)NCC1=CC=C(F)C=C1 FEHJERVYRFYEKP-UHFFFAOYSA-N 0.000 claims 1
- KJMLNMNUMFIPCL-UHFFFAOYSA-N chembl2362622 Chemical compound CC1CCCCN1C(=O)C1=C(NC(C=C2C(F)F)=C3CC3)N2N=C1 KJMLNMNUMFIPCL-UHFFFAOYSA-N 0.000 claims 1
- KCXGXZZNLYRATG-UHFFFAOYSA-N chembl3185805 Chemical compound C1=NN2C(C)=CC(=C)NC2=C1C(=O)NC1=CC=C(F)C=C1F KCXGXZZNLYRATG-UHFFFAOYSA-N 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical group C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 210000000265 leukocyte Anatomy 0.000 claims 1
- 230000011987 methylation Effects 0.000 claims 1
- 238000007069 methylation reaction Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- JTGDZISSXYTCKS-UHFFFAOYSA-N n-(2-fluoro-4-methylphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound FC1=CC(C)=CC=C1NC(=O)C1=C2N=C(C)C=C(C)N2N=C1 JTGDZISSXYTCKS-UHFFFAOYSA-N 0.000 claims 1
- YGMNTZSJEHOSOI-UHFFFAOYSA-N n-(3,5-dichlorophenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C=12N=C(C)C=C(C)N2N=CC=1C(=O)NC1=CC(Cl)=CC(Cl)=C1 YGMNTZSJEHOSOI-UHFFFAOYSA-N 0.000 claims 1
- UEAZOKNNUSCPBI-UHFFFAOYSA-N n-(4-acetylphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=CC(C(=O)C)=CC=C1NC(=O)C1=C2N=C(C)C=C(C)N2N=C1 UEAZOKNNUSCPBI-UHFFFAOYSA-N 0.000 claims 1
- QLEZIYRTMVTLGR-UHFFFAOYSA-N n-(4-ethylphenyl)-5-methyl-7-(4-propan-2-ylpiperazin-1-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=CC(CC)=CC=C1NC(=O)C1=C2N=C(C)C=C(N3CCN(CC3)C(C)C)N2N=C1 QLEZIYRTMVTLGR-UHFFFAOYSA-N 0.000 claims 1
- KFPLRJGVNOWDHO-UHFFFAOYSA-N n-(4-ethylphenyl)-5-methyl-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=CC(CC)=CC=C1NC(=O)C1=C2N=C(C)C=C(N3CCOCC3)N2N=C1 KFPLRJGVNOWDHO-UHFFFAOYSA-N 0.000 claims 1
- DQUDCBPQSRYTTL-UHFFFAOYSA-N n-(4-ethylphenyl)-5-methyl-7-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=CC(CC)=CC=C1NC(=O)C1=C2N=C(C)C=C(C=3C=CC=CC=3)N2N=C1 DQUDCBPQSRYTTL-UHFFFAOYSA-N 0.000 claims 1
- HVZPJBKUFRREQC-UHFFFAOYSA-N n-(4-ethynylphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C=12N=C(C)C=C(C)N2N=CC=1C(=O)NC1=CC=C(C#C)C=C1 HVZPJBKUFRREQC-UHFFFAOYSA-N 0.000 claims 1
- NBPAPVYPBXBLKO-UHFFFAOYSA-N n-(4-methoxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=C2N=C(C)C=C(C)N2N=C1 NBPAPVYPBXBLKO-UHFFFAOYSA-N 0.000 claims 1
- MCQYBGOYJAACFA-UHFFFAOYSA-N n-(4-tert-butylcyclohexyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C=12N=C(C)C=C(C)N2N=CC=1C(=O)NC1CCC(C(C)(C)C)CC1 MCQYBGOYJAACFA-UHFFFAOYSA-N 0.000 claims 1
- GJRAHOAOYTUESK-UHFFFAOYSA-N n-(4-tert-butylcyclohexyl)-5-(difluoromethyl)-7-methylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=NN2C(C)=CC(C(F)F)=NC2=C1C(=O)NC1CCC(C(C)(C)C)CC1 GJRAHOAOYTUESK-UHFFFAOYSA-N 0.000 claims 1
- XZGHKSOOTBYBOO-UHFFFAOYSA-N n-(4-tert-butylcyclohexyl)-5-methyl-6,7,8,9-tetrahydropyrazolo[1,5-a]quinazoline-3-carboxamide Chemical compound C1=NN2C=3CCCCC=3C(C)=NC2=C1C(=O)NC1CCC(C(C)(C)C)CC1 XZGHKSOOTBYBOO-UHFFFAOYSA-N 0.000 claims 1
- OXLAZSHQAKWVMG-UHFFFAOYSA-N n-(4-tert-butylcyclohexyl)-5-methyl-7-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound N12N=CC(C(=O)NC3CCC(CC3)C(C)(C)C)=C2N=C(C)C=C1C1=CC=CC=C1 OXLAZSHQAKWVMG-UHFFFAOYSA-N 0.000 claims 1
- GMWZLNUMPIJJDJ-UHFFFAOYSA-N n-[3-[3-(dimethylamino)phenyl]phenyl]-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound CN(C)C1=CC=CC(C=2C=C(NC(=O)C3=C4N=C(C)C=C(C)N4N=C3)C=CC=2)=C1 GMWZLNUMPIJJDJ-UHFFFAOYSA-N 0.000 claims 1
- WYAJXSUZTRSTPQ-UHFFFAOYSA-N n-[3-[4-(dimethylamino)phenyl]phenyl]-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=CC(NC(=O)C2=C3N=C(C)C=C(C)N3N=C2)=C1 WYAJXSUZTRSTPQ-UHFFFAOYSA-N 0.000 claims 1
- FOWNQDFHLGZQNE-UHFFFAOYSA-N n-[4-(3-cyanophenyl)phenyl]-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C=12N=C(C)C=C(C)N2N=CC=1C(=O)NC(C=C1)=CC=C1C1=CC=CC(C#N)=C1 FOWNQDFHLGZQNE-UHFFFAOYSA-N 0.000 claims 1
- HXRYZHDIPVUALS-UHFFFAOYSA-N n-[4-(4-methoxyphenyl)phenyl]-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(C=C1)=CC=C1NC(=O)C1=C2N=C(C)C=C(C)N2N=C1 HXRYZHDIPVUALS-UHFFFAOYSA-N 0.000 claims 1
- FXXLLYDCMKSODH-UHFFFAOYSA-N n-[4-[3-(dimethylamino)prop-1-ynyl]phenyl]-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=CC(C#CCN(C)C)=CC=C1NC(=O)C1=C2N=C(C)C=C(C)N2N=C1 FXXLLYDCMKSODH-UHFFFAOYSA-N 0.000 claims 1
- NNFHMGKJXHWDDP-UHFFFAOYSA-N n-[4-[4-(dimethylamino)phenyl]phenyl]-5,7-dimethylpyrazolo[1,5-a]pyrimidine-3-carboxamide Chemical compound C1=CC(N(C)C)=CC=C1C(C=C1)=CC=C1NC(=O)C1=C2N=C(C)C=C(C)N2N=C1 NNFHMGKJXHWDDP-UHFFFAOYSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42094610P | 2010-12-08 | 2010-12-08 | |
| US61/420,946 | 2010-12-08 | ||
| PCT/US2011/063928 WO2012078855A1 (en) | 2010-12-08 | 2011-12-08 | Substituted pyrazolopyrimidines as glucocerebrosidase activators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013544893A JP2013544893A (ja) | 2013-12-19 |
| JP2013544893A5 true JP2013544893A5 (enExample) | 2016-03-17 |
| JP6154746B2 JP6154746B2 (ja) | 2017-06-28 |
Family
ID=45498099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013543335A Active JP6154746B2 (ja) | 2010-12-08 | 2011-12-08 | グルコセレブロシダーゼ活性剤としての置換ピラゾロピリミジン類 |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US9353117B2 (enExample) |
| EP (2) | EP3366688B1 (enExample) |
| JP (1) | JP6154746B2 (enExample) |
| KR (1) | KR101931224B1 (enExample) |
| CN (1) | CN103534255B (enExample) |
| AU (1) | AU2011338377B2 (enExample) |
| BR (1) | BR112013014242B1 (enExample) |
| CA (1) | CA2820362C (enExample) |
| CY (1) | CY1125186T1 (enExample) |
| DK (2) | DK3366688T3 (enExample) |
| ES (2) | ES2681218T3 (enExample) |
| HR (1) | HRP20220512T1 (enExample) |
| HU (1) | HUE038635T2 (enExample) |
| IL (2) | IL226767B (enExample) |
| LT (1) | LT3366688T (enExample) |
| MX (2) | MX354506B (enExample) |
| PL (2) | PL2649075T3 (enExample) |
| PT (2) | PT3366688T (enExample) |
| RS (1) | RS63320B1 (enExample) |
| RU (1) | RU2603637C2 (enExample) |
| SI (2) | SI2649075T1 (enExample) |
| TR (1) | TR201810523T4 (enExample) |
| WO (1) | WO2012078855A1 (enExample) |
| ZA (1) | ZA201304215B (enExample) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2681218T3 (es) | 2010-12-08 | 2018-09-12 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Pirazolopirimidinas sustituidas como activadoras de la glucocerebrosidasa |
| EP2723746A1 (en) | 2011-06-22 | 2014-04-30 | Vertex Pharmaceuticals Inc. | Compounds useful as inhibitors of atr kinase |
| CA2840224C (en) * | 2011-06-22 | 2019-08-13 | The General Hospital Corporation | Treatment of proteinopathies |
| AU2012272898A1 (en) | 2011-06-24 | 2013-04-11 | Amgen Inc. | TRPM8 antagonists and their use in treatments |
| CA2839699A1 (en) | 2011-06-24 | 2012-12-27 | Amgen Inc. | Trpm8 antagonists and their use in treatments |
| CN104394869A (zh) * | 2011-10-20 | 2015-03-04 | 葛兰素史密斯克莱有限责任公司 | 用作沉默调节蛋白调节剂的取代的双环氮杂杂环化合物和类似物 |
| US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| US8952009B2 (en) | 2012-08-06 | 2015-02-10 | Amgen Inc. | Chroman derivatives as TRPM8 inhibitors |
| US9340546B2 (en) | 2012-12-07 | 2016-05-17 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| WO2014143242A1 (en) | 2013-03-15 | 2014-09-18 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
| JP2016512239A (ja) | 2013-03-15 | 2016-04-25 | バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | Ａｔｒキナーゼの阻害剤として有用な化合物 |
| US9663519B2 (en) | 2013-03-15 | 2017-05-30 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| EA201690713A1 (ru) | 2013-10-04 | 2016-08-31 | Инфинити Фармасьютикалз, Инк. | Гетероциклические соединения и их применения |
| WO2015051241A1 (en) | 2013-10-04 | 2015-04-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| WO2015085132A1 (en) | 2013-12-06 | 2015-06-11 | Vertex Pharmaceuticals Incorporated | 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, its preparation, different solid forms and radiolabelled derivatives thereof |
| EP4066834A1 (en) | 2014-03-19 | 2022-10-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders |
| CN107074863B (zh) | 2014-06-05 | 2019-12-03 | 沃泰克斯药物股份有限公司 | Atr激酶抑制剂的制备方法及其不同的固体形式 |
| CA2950780C (en) | 2014-06-17 | 2023-05-16 | Vertex Pharmaceuticals Incorporated | Method for treating cancer using a combination of chk1 and atr inhibitors |
| US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
| CN107108638A (zh) | 2014-11-03 | 2017-08-29 | 拜耳制药股份公司 | 哌啶基吡唑并嘧啶酮及其用途 |
| WO2016073891A1 (en) | 2014-11-06 | 2016-05-12 | Lysosomal Therapeutics Inc. | Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders |
| SMT202400187T1 (it) | 2014-11-06 | 2024-07-09 | Bial R&D Investments S A | Pirazolo(1,5-a)pirimidine sostituite e loro utilizzo nel trattamento di disturbi medici |
| ES2958391T3 (es) | 2014-11-06 | 2024-02-08 | Bial R&D Invest S A | Imidazo[1,5-a]pirimidinas sustituidas y su uso en el tratamiento de trastornos médicos |
| WO2017004408A1 (en) | 2015-07-01 | 2017-01-05 | Northwestern University | Substituted 4-methyl-pyrrolo[1.2-a]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity |
| WO2017040879A1 (en) * | 2015-09-04 | 2017-03-09 | Lysosomal Therapeutics Inc. | Thiazolo(3,2-a) pyrimidinone and other heterobicyclic pyrimidinone compounds for use in medical therapy |
| WO2017040877A1 (en) * | 2015-09-04 | 2017-03-09 | Lysosomal Therapeutics Inc. | Heterobicyclic pyrimidinone compounds and their use in the treatment of medical disorders |
| NZ740616A (en) | 2015-09-14 | 2023-05-26 | Infinity Pharmaceuticals Inc | Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same |
| HK1258570A1 (zh) | 2015-09-30 | 2019-11-15 | Vertex Pharmaceuticals Inc. | 使用dna损伤剂及atr抑制剂的组合治疗癌症的方法 |
| WO2017161137A1 (en) * | 2016-03-16 | 2017-09-21 | Lysosomal Therapeutics Inc. | Methods and compositions for treating a neurodegenerative disorder in a sphingotyped subject |
| WO2017161116A1 (en) | 2016-03-17 | 2017-09-21 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors |
| SG11201808830YA (en) * | 2016-04-06 | 2018-11-29 | Lysosomal Therapeutics Inc | Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders |
| CA3020305A1 (en) | 2016-04-06 | 2017-10-12 | Lysosomal Therapeutics Inc. | Imidazo [1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders |
| EP3440081A4 (en) * | 2016-04-06 | 2019-09-18 | Lysosomal Therapeutics Inc. | PYRROLO [1,2-A] PYRIMIDINYL-CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDER |
| WO2017192929A1 (en) * | 2016-05-05 | 2017-11-09 | Lysosomal Therapeutics Inc. | SUBSTITUTED PYRROLO[1,2-α]TRIAZINES AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS |
| WO2017192931A1 (en) * | 2016-05-05 | 2017-11-09 | Lysosomal Therapeutics Inc. | SUBSTITUTED IMDAZO[1,2-α]PYRIDINES, SUBSTITUTED IMIDAZO[1,2-α]PYRAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS |
| JP7164774B2 (ja) * | 2016-05-05 | 2022-11-02 | ビアル－アール・アンド・ディ・インベストメンツ・ソシエダーデ・アノニマ | 置換イミダゾ［１，２－ｂ］ピリダジン、置換イミダゾ［１，５－ｂ］ピリダジン、関連化合物、および医学的障害の治療におけるその使用 |
| US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| JP7059268B2 (ja) * | 2016-11-02 | 2022-04-25 | エフ．ホフマン－ラ ロシュ アーゲー | ＩＲＡＫ４モデュレーターとしてのピラゾロ［１，５ａ］ピリミジン誘導体 |
| CN111194317A (zh) * | 2017-07-28 | 2020-05-22 | 林伯士拉克许米公司 | Tyk2抑制剂与其用途 |
| CN111386259A (zh) | 2017-08-02 | 2020-07-07 | 西北大学 | 经取代稠合的嘧啶化合物及其用途 |
| CA3072362A1 (en) | 2017-10-06 | 2019-04-11 | Forma Therapeutics, Inc. | Inhibiting ubiquitin specific peptidase 30 |
| EP3747885A4 (en) | 2018-01-31 | 2021-11-03 | Takeda Pharmaceutical Company Limited | HETEROCYCLIC COMPOUND |
| CA3098628A1 (en) | 2018-05-17 | 2019-11-21 | Forma Therapeutics, Inc. | Fused bicyclic compounds useful as ubiquitin-specific peptidase 30 inhibitors |
| US10882865B2 (en) | 2018-08-31 | 2021-01-05 | Northwestern University | Pyrrolopyrimidine compounds and uses thereof for modulating glucocerebrosidase activity |
| US11891400B2 (en) | 2018-09-10 | 2024-02-06 | Eli Lilly And Company | Pyrazolo[1,5-a]pyrimidine-3-carboxamide derivatives useful in the treatment of psoriasis and systemic lupus erythematosus |
| RS64321B1 (sr) | 2018-10-05 | 2023-08-31 | Forma Therapeutics Inc | Fuzionisani pirolini koji se ponašaju kao inhibitori ubikvitin specifične proteaze 30 (usp30) |
| CN113271940A (zh) * | 2018-10-15 | 2021-08-17 | 林伯士拉克许米公司 | Tyk2抑制剂和其用途 |
| TWI800696B (zh) | 2018-12-10 | 2023-05-01 | 美商美國禮來大藥廠 | 7-(甲基胺基)吡唑并[1,5-a]嘧啶-3-甲醯胺衍生物 |
| US20220332720A1 (en) * | 2019-08-21 | 2022-10-20 | The Scripps Research Institute | Bicyclic agonists of stimulator of interferon genes sting |
| EP4031531A1 (en) | 2019-09-17 | 2022-07-27 | Bial-R&D Investments, S.A. | Substituted imidazole carboxamides and their use in the treatment of medical disorders |
| CA3151022A1 (en) | 2019-09-17 | 2021-03-25 | Bial - R&D Investments, S.A. | Substituted n-heterocyclic carboxamides as acid ceramidase inhibitors and their use as medicaments |
| JP2022549227A (ja) | 2019-09-17 | 2022-11-24 | バイアル－アールアンドディー インベストメンツ ソシエダッド アノニマ | 医学的障害の治療における使用のための置換された飽和および不飽和ｎ－複素環式カルボキサミドおよび関連化合物 |
| CN115397806A (zh) * | 2019-11-25 | 2022-11-25 | 增益治疗股份有限公司 | 芳基和杂芳基化合物及其在与半乳糖脑苷脂酶的活性改变相关的病状中的治疗用途 |
| AR121251A1 (es) | 2020-02-12 | 2022-05-04 | Lilly Co Eli | Compuestos de 7-(metilamino)pirazolo[1,5-a]pirimidina-3-carboxamida |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004037373A2 (en) | 2002-10-21 | 2004-05-06 | The Scripps Research Institute | CHEMICAL CHAPERONES AND THEIR EFFECT UPON THE CELLULAR ACTIVITY OF β-GLUCOSIDASE |
| JP2004277337A (ja) * | 2003-03-14 | 2004-10-07 | Sumitomo Pharmaceut Co Ltd | ピラゾロ［１，５−ａ］ピリミジン誘導体 |
| WO2004089471A2 (en) * | 2003-04-11 | 2004-10-21 | Novo Nordisk A/S | NEW PYRAZOLO[1,5-a] PYRIMIDINES DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| EP1682134A4 (en) | 2003-11-12 | 2008-10-15 | Amicus Therapeutics Inc | GLUCOIMIDAZOLE AND POLYHYDROXYCYCLOHEXENYL-AMINE DERIVATIVES FOR THE TREATMENT OF GAUCHER DISEASE |
| CA2507348C (en) | 2004-05-13 | 2013-07-16 | The Hospital For Sick Children | Real time methylumbelliferone-based assay |
| WO2005113004A2 (en) * | 2004-05-14 | 2005-12-01 | The Cleveland Clinic Founfation | Small molecule inhibitors for mrp1 and other multidrug transporters |
| AU2005254657B2 (en) * | 2004-06-21 | 2011-03-17 | F. Hoffmann-La Roche Ag | Pyrrazolo-pyrimidine derivatives |
| DE102005007534A1 (de) * | 2005-02-17 | 2006-08-31 | Bayer Cropscience Ag | Pyrazolopyrimidine |
| US20070155737A1 (en) | 2005-05-20 | 2007-07-05 | Alantos Pharmaceuticals, Inc. | Heterobicyclic metalloprotease inhibitors |
| AU2006251989B2 (en) | 2005-05-20 | 2010-05-27 | Alantos-Pharmaceuticals, Inc. | Pyrimidine or triazine fused bicyclic metalloprotease inhibitors |
| WO2007008541A2 (en) | 2005-07-08 | 2007-01-18 | Kalypsys, Inc. | Cellular cholesterol absorption modifiers |
| BRPI0614577A2 (pt) | 2005-08-15 | 2011-04-05 | Hoffmann La Roche | derivados de piperidina e piperazina como antagonistas de p2x3 |
| WO2007048066A2 (en) * | 2005-10-21 | 2007-04-26 | Exelixis, Inc. | Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators |
| AR056876A1 (es) * | 2005-10-21 | 2007-10-31 | Tanabe Seiyaku Co | Compuestos de pirazolo[1-5-a]pirimidina, antagonistas de receptores canabinoides cb1, composiciones farmaceuticas que los contienen y usos en el tratamiento de enfermedades del sistema nervioso central, tales como trastornos psicoticos, neurologicos y similares |
| WO2008054947A2 (en) | 2006-10-02 | 2008-05-08 | The Brigham And Women's Hospital, Inc. | Structure of acid beta-glucosidase and methods for identifying therapeutic agents |
| US20090275586A1 (en) | 2006-10-06 | 2009-11-05 | Kalypsys, Inc. | Heterocyclic inhibitors of pde4 |
| US20080176870A1 (en) | 2006-11-20 | 2008-07-24 | Bert Nolte | Heterobicyclic metalloprotease inhibitors |
| US8399525B2 (en) | 2007-04-13 | 2013-03-19 | Amicus Therapeutics, Inc. | Treatment of gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markers |
| WO2008134035A1 (en) | 2007-04-27 | 2008-11-06 | Panacos Pharmaceuticals, Inc. | Alpha-unsubstituted arylmethyl piperazine pyrazolo[1,5-a] pyrimidine amide derivatives |
| ES2559859T3 (es) | 2007-05-16 | 2016-02-16 | The Brigham And Women's Hospital, Inc. | Tratamiento de sinucleinopatías |
| WO2008154207A1 (en) | 2007-06-08 | 2008-12-18 | The Burnham Institute For Medical Research | Methods and compounds for regulating apoptosis |
| JP5337405B2 (ja) | 2007-09-17 | 2013-11-06 | ザ・ホスピタル・フォー・シック・チルドレン | ゴーシェ病の治療方法 |
| WO2009049421A1 (en) | 2007-10-18 | 2009-04-23 | The Hospital For Sick Children | Compositions and methods for enhancing enzyme activity in gaucher, gm1-gangliosidosis/morquio b disease, and parkinson's disease |
| EP2219646A4 (en) * | 2007-12-21 | 2010-12-22 | Univ Rochester | PROCESS FOR EXTENDING THE LIFE OF EUKARYOTIC ORGANISMS |
| CN102112478A (zh) * | 2008-06-10 | 2011-06-29 | 普莱希科公司 | 用于激酶调节的5h-吡咯[2，3-b]吡嗪衍生物和其适应症 |
| CA2729766A1 (en) * | 2008-07-01 | 2010-01-07 | Zacharon Pharmaceuticals, Inc. | Heparan sulfate inhibitors |
| WO2010086040A1 (en) * | 2009-01-29 | 2010-08-05 | Biomarin Iga, Ltd. | Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy |
| ES2681218T3 (es) | 2010-12-08 | 2018-09-12 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Pirazolopirimidinas sustituidas como activadoras de la glucocerebrosidasa |
| SMT202400187T1 (it) * | 2014-11-06 | 2024-07-09 | Bial R&D Investments S A | Pirazolo(1,5-a)pirimidine sostituite e loro utilizzo nel trattamento di disturbi medici |
-
2011
- 2011-12-08 ES ES11810714.3T patent/ES2681218T3/es active Active
- 2011-12-08 PT PT181650052T patent/PT3366688T/pt unknown
- 2011-12-08 BR BR112013014242-1A patent/BR112013014242B1/pt active IP Right Grant
- 2011-12-08 DK DK18165005.2T patent/DK3366688T3/da active
- 2011-12-08 PL PL11810714T patent/PL2649075T3/pl unknown
- 2011-12-08 KR KR1020137017520A patent/KR101931224B1/ko active Active
- 2011-12-08 RS RS20220422A patent/RS63320B1/sr unknown
- 2011-12-08 US US13/991,816 patent/US9353117B2/en active Active
- 2011-12-08 SI SI201131532T patent/SI2649075T1/sl unknown
- 2011-12-08 JP JP2013543335A patent/JP6154746B2/ja active Active
- 2011-12-08 RU RU2013126094/04A patent/RU2603637C2/ru active
- 2011-12-08 ES ES18165005T patent/ES2912284T3/es active Active
- 2011-12-08 CN CN201180066859.7A patent/CN103534255B/zh active Active
- 2011-12-08 MX MX2013006462A patent/MX354506B/es active IP Right Grant
- 2011-12-08 WO PCT/US2011/063928 patent/WO2012078855A1/en not_active Ceased
- 2011-12-08 AU AU2011338377A patent/AU2011338377B2/en active Active
- 2011-12-08 CA CA2820362A patent/CA2820362C/en active Active
- 2011-12-08 DK DK11810714.3T patent/DK2649075T3/en active
- 2011-12-08 MX MX2018000385A patent/MX385600B/es unknown
- 2011-12-08 PL PL18165005T patent/PL3366688T3/pl unknown
- 2011-12-08 HU HUE11810714A patent/HUE038635T2/hu unknown
- 2011-12-08 EP EP18165005.2A patent/EP3366688B1/en active Active
- 2011-12-08 LT LTEP18165005.2T patent/LT3366688T/lt unknown
- 2011-12-08 SI SI201132052T patent/SI3366688T1/sl unknown
- 2011-12-08 EP EP11810714.3A patent/EP2649075B1/en active Active
- 2011-12-08 PT PT118107143T patent/PT2649075T/pt unknown
- 2011-12-08 HR HRP20220512TT patent/HRP20220512T1/hr unknown
- 2011-12-08 TR TR2018/10523T patent/TR201810523T4/tr unknown
-
2013
- 2013-06-06 IL IL226767A patent/IL226767B/en active IP Right Grant
- 2013-06-07 ZA ZA2013/04215A patent/ZA201304215B/en unknown
-
2016
- 2016-04-28 US US15/141,275 patent/US9974789B2/en active Active
-
2018
- 2018-05-18 US US15/983,844 patent/US10925874B2/en active Active
- 2018-05-28 IL IL259648A patent/IL259648B/en active IP Right Grant
-
2022
- 2022-05-04 CY CY20221100316T patent/CY1125186T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013544893A5 (enExample) | ||
| RU2435771C2 (ru) | Производные спироиндолинона | |
| TWI579284B (zh) | 咪唑并吡咯啶酮化合物 | |
| JP7196270B2 (ja) | 置換アミノプリン化合物、その組成物、及びそれによる治療の方法 | |
| FI3932919T3 (fi) | Jak-inhibiittoriyhdiste ja sen käyttö | |
| US20040097503A1 (en) | Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof | |
| KR20210019581A (ko) | Nav1.8을 억제하기 위한 피리딘 카르복스아미드 화합물 | |
| AU2013305634B2 (en) | Novel 4,6-disubstituted aminopyrimidine derivatives | |
| RU2010103813A (ru) | Пиримидилциклопентаны как ингибиторы акт протеинкиназ | |
| RU2018126815A (ru) | Бициклические гидроксамовые кислоты, полезные в качестве ингибиторов активности деацетилазы гистонов млекопитающих | |
| RU2007146390A (ru) | Соединения и композиции в качестве ингибиторов протеинкиназ | |
| EP1351691A1 (en) | Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof | |
| KR20170103838A (ko) | 염증 및 암의 치료를 위한 헤테로시클릭 itk 저해제 | |
| JP2009515949A5 (enExample) | ||
| RU2015148926A (ru) | Аза-оксо-индолы для лечения и профилактики респираторно-синцитиальной вирусной инфекции | |
| RU2014152790A (ru) | Пирролопиразоновые ингибиторы танкиразы | |
| RU2013106755A (ru) | 1,4,5,6-тетрагидропиримидин-2-иламины | |
| RU2006146632A (ru) | Производные хиназолинона, полезные в качестве ванилоидных антагонистов | |
| RU2015144385A (ru) | Ациклические цианоэтилпиразолопиридоны в качестве ингибиторов янус-киназы | |
| JP2019507122A (ja) | クリプトスポリジウム症の治療のための化合物および組成物 | |
| JP2015524843A5 (enExample) | ||
| RU2010141578A (ru) | Производные (пиразолилкарбонил)имидазолидинона, предназначенные для лечения ретровирусных заболеваний | |
| RU2009101920A (ru) | ПРОИЗВОДНЫЕ 4-АМИНО-3-АРИЛАМИНО-6-АРИЛПИРАЗОЛО[3,4-d]ПИРИМИДИНА, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ПРОТИВОВИРУСНЫХ СРЕДСТВ | |
| EP1539761B1 (en) | 6,7-dihydro-5h-pyrazolo¬1,2-a pyrazol-1-ones which control inflammatory cytokines | |
| FI4225753T3 (fi) | Voimakkaita ja selektiivisiä yhdisteitä serotoniini 1b -reseptorin modulaattoreina |